Aprea Therapeutics Inc (APRE)

12:48 PM

Tools to assess Aprea Therapeutics Inc.’s risk profileWeekly Stock Report & High Return Trade Guides - newser.com

12:48 PM

06:20 AM

Is Aprea Therapeutics Inc. stock attractive for growth ETFsJuly 2025 Action & Fast Entry and Exit Trade Plans - newser.com

06:20 AM

04:30 AM

Will Aprea Therapeutics Inc. stock outperform value stocksJuly 2025 Catalysts & Safe Entry Momentum Stock Tips - newser.com

04:30 AM

04:26 AM

Is Aprea Therapeutics Inc. stock attractive after correction2025 Sector Review & Growth Oriented Trade Recommendations - newser.com

04:26 AM

Nov 03, 2025

Aprea Therapeutics (Nasdaq: APRE) Transforms Cutting-Edge - openPR.com

Nov 03, 2025

Nov 03, 2025

Aprea Therapeutics (Nasdaq: APRE) Transforms Cutting-Edge Science into Next-Generation Cancer Therapies – More Stocks Inside - FinancialContent

Nov 03, 2025

Nov 03, 2025

Aprea Therapeutics Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView

Nov 03, 2025

Nov 03, 2025

Is Aprea Therapeutics Inc. stock poised for growthPortfolio Update Summary & AI Forecast for Swing Trade Picks - newser.com

Nov 03, 2025

Nov 03, 2025

Why Aprea Therapeutics Inc. stock could outperform in 2025Trade Exit Summary & Low Risk High Win Rate Picks - newser.com

Nov 03, 2025

Nov 02, 2025

Risk vs reward if holding onto Aprea Therapeutics Inc.Portfolio Risk Summary & Free Technical Pattern Based Buy Signals - newser.com

Nov 02, 2025

Oct 31, 2025

Aprea Therapeutics Reports Early Signs of Activity in APR-1051 Cancer Trial - MyChesCo

Oct 31, 2025

Oct 31, 2025

Aprea Therapeutics Advances ATRN-119 Study for Solid Tumors - MSN

Oct 31, 2025

Oct 30, 2025

Aprea Therapeutics, Inc. (APRE) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 30, 2025

Oct 29, 2025

Aprea Therapeutics, Inc.Common Stock (Nasdaq:APRE) Stock Quote | PRN_FinancialWrapper | PR Newswire - FinancialContent

Oct 29, 2025

Oct 29, 2025

How Aprea Therapeutics Inc. stock reacts to global recession fearsQuarterly Investment Review & Verified Technical Trade Signals - Fundação Cultural do Pará

Oct 29, 2025

Oct 28, 2025

Will Aprea Therapeutics Inc. stock outperform tech sector in 2025Market Performance Report & Low Drawdown Investment Ideas - fcp.pa.gov.br

Oct 28, 2025

Oct 28, 2025

Meme Stocks: How Aprea Therapeutics Inc. stock performs in weak economy2025 Earnings Surprises & Accurate Technical Buy Alerts - Fundação Cultural do Pará

Oct 28, 2025

Oct 27, 2025

Update Recap: Will Aprea Therapeutics Inc. stock deliver shareholder value2025 Earnings Surprises & Low Risk Entry Point Tips - fcp.pa.gov.br

Oct 27, 2025

Oct 27, 2025

Aprea Therapeutics Advances with Phase 1 Study of APR-1051 in Solid Tumors - TipRanks

Oct 27, 2025

Oct 24, 2025

Aprea’s WEE1 inhibitor shows disease stabilization in early trial - Investing.com

Oct 24, 2025

Oct 24, 2025

Aprea’s WEE1 inhibitor shows disease stabilization in early trial By Investing.com - Investing.com South Africa

Oct 24, 2025

Oct 24, 2025

Aprea Therapeutics Reports Promising Trial Results for APR-1051 - TipRanks

Oct 24, 2025

Oct 24, 2025

Aprea sees early activity in APR-1051 Wee1 trial - MarketScreener

Oct 24, 2025

Oct 24, 2025

Aprea Therapeutics Provides Clinical Update on ACESOT-1051 Trial - TradingView

Oct 24, 2025